Drug
Actr087
Actr087: highest development phase Phase 1, developed by Seagen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Seagen
Trials
| Drug | Phase | Indication |
|---|---|---|
| ACTR087 NCT03266692 | Phase 1 | Multiple Myeloma |
Latest
No recent events.
Follow Actr087 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.